Shoujun Tang

764 total citations · 1 hit paper
11 papers, 287 citations indexed

About

Shoujun Tang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Shoujun Tang has authored 11 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Shoujun Tang's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Aortic Disease and Treatment Approaches (2 papers). Shoujun Tang is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Aortic Disease and Treatment Approaches (2 papers). Shoujun Tang collaborates with scholars based in China, Switzerland and Australia. Shoujun Tang's co-authors include Haining Zhou, Shengjie Tang, Haiyang Hu, Hang Yan, Chao Qin, Tao Liu, Jun Zhang, Shuangjiang Li, Tao Liu and I.T.M. Kung and has published in prestigious journals such as Cancer Letters, Frontiers in Pharmacology and Cells.

In The Last Decade

Shoujun Tang

11 papers receiving 283 citations

Hit Papers

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cance... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoujun Tang China 7 129 128 115 86 34 11 287
Linpeng Zheng China 10 207 1.6× 150 1.2× 77 0.7× 71 0.8× 37 1.1× 17 304
Dian Ren China 12 136 1.1× 165 1.3× 95 0.8× 76 0.9× 17 0.5× 26 325
Kammei Rai Japan 8 104 0.8× 138 1.1× 144 1.3× 112 1.3× 21 0.6× 34 333
D. Viñal Spain 10 166 1.3× 90 0.7× 88 0.8× 33 0.4× 45 1.3× 33 285
Viktoria Stühler Germany 12 96 0.7× 157 1.2× 139 1.2× 76 0.9× 28 0.8× 34 308
Jiazheng Cao China 11 83 0.6× 140 1.1× 260 2.3× 173 2.0× 38 1.1× 28 387
Kakeru Hisakane Japan 10 179 1.4× 215 1.7× 77 0.7× 67 0.8× 13 0.4× 35 336
Shaochuan Liu China 9 237 1.8× 89 0.7× 106 0.9× 54 0.6× 121 3.6× 15 362
Arnab Basu United States 9 165 1.3× 126 1.0× 62 0.5× 58 0.7× 35 1.0× 49 284

Countries citing papers authored by Shoujun Tang

Since Specialization
Citations

This map shows the geographic impact of Shoujun Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoujun Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoujun Tang more than expected).

Fields of papers citing papers by Shoujun Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoujun Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoujun Tang. The network helps show where Shoujun Tang may publish in the future.

Co-authorship network of co-authors of Shoujun Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Shoujun Tang. A scholar is included among the top collaborators of Shoujun Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoujun Tang. Shoujun Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhou, Haining, et al.. (2024). 348. MANAGEMENT OF AORTO-ESOPHAGEAL FIFISTULA SECONDARY AFTER THORACIC ENDOVASCULAR AORTIC REPAIR. Diseases of the Esophagus. 37(Supplement_1). 1 indexed citations
2.
Yu, Li, Hang Yan, Shengjie Tang, et al.. (2023). LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers. Frontiers in Molecular Biosciences. 10. 1297198–1297198. 5 indexed citations
3.
Tang, Shengjie, Chao Qin, Haiyang Hu, et al.. (2022). Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects. Cells. 11(3). 320–320. 128 indexed citations breakdown →
4.
Yan, Hang, Shengjie Tang, Shoujun Tang, et al.. (2022). miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential. Frontiers in Pharmacology. 13. 949566–949566. 17 indexed citations
5.
Qin, Chao, Hang Yan, Tao Liu, et al.. (2022). Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives. Cells. 11(20). 3200–3200. 53 indexed citations
6.
Tang, Shengjie, et al.. (2021). MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer. Cancer Letters. 502. 71–83. 44 indexed citations
7.
Hu, Haiyang, et al.. (2021). Asymptomatic Giant Left Atrial Appendage Cavernous Haemangiona Misdiagnosed as a Mediastinal Mass. Heart Lung and Circulation. 31(1). e12–e13. 1 indexed citations
8.
He, Yiwei, Shoujun Tang, Yongheng Zhang, Jianping Liu, & Haining Zhou. (2020). Re-TEVAR in treatment of stent graft-induced new entry between two non-overlapping stent-grafts: a case report. Journal of Cardiothoracic Surgery. 15(1). 314–314. 1 indexed citations
9.
Zhou, Haining, et al.. (2018). Hybrid surgery in treatment of pulmonary sequestration with abdominal aorta feeding vessel: a case report. Journal of Cardiothoracic Surgery. 13(1). 44–44. 15 indexed citations
10.
Zhou, Haining, et al.. (2017). Thoracoscopic resection of a huge mediastinal cystic lymphangioma. Journal of Thoracic Disease. 9(10). E887–E889. 10 indexed citations
11.
Clark, Simon, I.T.M. Kung, & Shoujun Tang. (1992). Fine‐needle aspiration of cystic nephroma (multilocular cyst of the kidney). Diagnostic Cytopathology. 8(4). 349–351. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026